Categories: AnalystsCannabis

Sunniva stock is a double, Beacon Securities says

Cannabis company Sunniva Inc. (Sunniva Stock Quote, Chart CSE:SNN) has announced its intention to spin out its Canadian assets to list on the TSX and the Nasdaq and to leave its US assets to trade on the CSE. Analyst Doug Cooper of Beacon Securities calls the move a great value creation play which will further the company’s M&A strategy in California.

Sunniva is currently in the middle of constructing a 489,000 sq. ft. facility in Cathedral City, California, which is projected to produce up to 160,000 kg of cannabis annually (scheduled to be fully operational in Q3/18), while in Canada, Sunniva is in the early stages of building a 100,000 kg facility in Okanagan Falls, BC.

The California facility intends for 30 per cent of its product to be used for higher margin extracted products, a value-added strategy which Cooper says could generate over US$500 in revenue at a 30 per cent EBTIDA margin for Sunniva.

In Canada, Sunniva has signed a two-year contract with industry-leading Canopy Growth Corp. for 45 per cent of its BC production, which Cooper says implies a cash flow of $270 million, more than the current market cap of the company itself. The company also operates a network of seven medical cannabis clinics in Canada under the name Natural Health Service.

Sunniva stock has value

All told, Cooper says there’s a lot of undiscovered value in Sunnia.

“We believe having unencumbered US assets is very important and frees up the company to aggressively pursue an M&A strategy within the largest cannabis market in the world (California),” the analyst said in an update to clients on Tuesday. “SNN has a current EV of ~$220 million, which neither reflects the true value of the US nor Canadian assets.”

As for the prospects of the intended spinoff, CEO Dr. Anthony Holler is optimistic.

“Creating a new Canadian company with our Canadian assets and listing them on the TSX and NASDAQ would be expected to bring added visibility and additional analyst coverage to our story and has the potential to attract institutional investors that are currently unable to purchase stock on the CSE or purchase companies holding US assets.”

In his Tuesday update, Cooper reiterated his “Speculative Buy” rating and $16.50 target price for SNN, representing a potential return of 105 per cent at the time of publication.

Tagged with: snn
Jayson MacLean

Jayson is a writer, researcher and educator with a PhD in political philosophy from the University of Ottawa. His interests range from bioethics and innovations in the health sciences to governance, social justice and the history of ideas.

Recent Posts

Booking Holdings is “best in class”, this investor says

In an appearance on BNN Bloomberg Market Call on April 8, First Avenue Investment Counsel chief investment officer Brian Madden… [Read More]

23 hours ago

Should you sell your NowVertical stock?

Ventum Capital Markets analyst Robb Goff cut his target on NowVertical Group (NowVertical Group Stock Quote, Chart, News, Analysts, Financials… [Read More]

24 hours ago

This analyst says Constellation Brands is a “Top Pick”

Roth Capital Markets analyst Bill Kirk reiterated his “Top Pick” and “Buy” rating on Constellation Brands (Constellation Brands Stock Quote,… [Read More]

24 hours ago

Here’s why Micron is a great AI play

Micron Technology (Micron Technology Stock Quote, Chart, News, Analysts, Financials NASDAQ:MU) remains an underappreciated AI name, according to Forvest Global… [Read More]

1 day ago

This analyst just slashed his price target on Byrna Technologies

Roth Capital Markets analyst Matt Koranda maintained his “Buy” rating on Byrna Technologies (Byrna Technologies Stock Quote, Chart, News, Analysts,… [Read More]

1 day ago

Beacon raises price target on Firan Technology to $26.00

Beacon Securities analyst Russell Stanley raised his target on Firan Technology Group (Firan Technology Group Stock Quote, Chart, News, Analysts,… [Read More]

2 days ago